Results from the UK NCRI Adjuvant Breast Cancer (ABC) International trial: Polychemotherapy and ovarian ablation in women with early breast cancer prescribed 5 years tamoxifen.

被引：0
|
作者：
Brunt, AM
Bliss, JM
Johnson, L
Lawrence, D
Yarnold, J
机构：
来源：
BRITISH JOURNAL OF CANCER | 2004年 / 91卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1 / S1
页数：1
相关论文
共 50 条
  • [1] Polychemotherapy (CT) in pre- and post-menopausal women with early breast cancer prescribed 5 years tamoxifen (T) - results from the UKNCRI Adjuvant Breast Cancer (ABC) international trial in 1991 patients.
    Barrett-Lee, PJ
    Bliss, JM
    Brunt, AM
    Dehshiri, K
    Harnett, AN
    Johnson, L
    Lawrence, D
    Robinson, A
    Weerasekera, K
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 41S - 41S
  • [2] Ovarian ablation (DA) in pre-menopausal women with early breast cancer prescribed 5 years tamoxifen (T) or T+ chemotherapy (CT)- results from the UKNCRI Adjuvant Breast Cancer (ABC) international trial of 2,144 patients
    Yarnold, JR
    Bliss, JM
    Earl, H
    George, D
    Lawrence, D
    Mortazavi, SH
    Perren, TJ
    Raina, V
    Spooner, D
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 11S - 11S
  • [3] Polychemotherapy for early breast cancer: Results from the international adjuvant breast cancer chemotherapy randomized trial
    不详
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (07): : 506 - 515
  • [4] Re: Polychemotherapy for early breast cancer: Results from the International Adjuvant Breast Cancer Chemotherapy Randomized Trial
    Ferretti, Gianluigi
    Felici, Alessandra
    Carlini, Paolo
    Cognetti, Francesco
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (18): : 1416 - 1416
  • [5] Ovarian ablation or suppression in premenopausal early breast cancer: Results from the international adjuvant breast cancer ovarian ablation or suppression randomized trial
    Bliss, J. M.
    Johnson, L.
    Lawrence, D.
    Peto, J.
    Price, D.
    Yarnold, J.
    Barrett-Lee, P.
    Brunt, A. M.
    Dodwell, D.
    Earl, H.
    Fernando, I.
    Foster, L.
    George, W. D.
    Harnett, A. M.
    Perren, T.
    Poole, C.
    Raina, V.
    Robinson, A.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (07): : 516 - 525
  • [6] Re: Ovarian ablation or suppression in premenopausal early breast cancer: Results from the International Adjuvant Breast Cancer ovarian Ablation or Suppression Randomized Trial
    Ferretti, Gianluigi
    Felici, Alessandra
    Carlini, Paolo
    Cognetti, Francesco
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (17): : 1344 - 1345
  • [7] ATLAS (ADJUVANT TAMOXIFEN, LONGER AGAINST SHORTER): 10 VERSUS 5 YEARS OF ADJUVANT TAMOXIFEN - INITIAL RESULTS FROM AN INTERNATIONAL RANDOMISED TRIAL AMONG 11,607 WOMEN WITH EARLY BREAST CANCER
    Davies, C.
    Godwin, J.
    Peto, R.
    Arriagada, R.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S102 - S102
  • [8] Cost-effectiveness of five years of extended adjuvant letrozole in postmenopausal women with early breast cancer who have completed five years of adjuvant tamoxifen.
    Delea, TE
    Karnon, J
    Smith, RE
    Brandman, J
    Sung, JC
    Goss, PPE
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S58 - S58
  • [9] Randomized trial of 2 versus 5 years of adjuvant tamoxifen for women aged 50 years or older with early breast cancer: Italian Interdisciplinary Group for Cancer Evaluation study of adjuvant treatment in breast cancer 01
    Sacco, M
    Valentini, M
    Belfiglio, M
    Pellegrini, F
    De Berardis, G
    Franciosi, M
    Nicolucci, A
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (12) : 2276 - 2281
  • [10] Updated results of a randomized trial of 2 versus 5 years of adjuvant tamoxifen for women aged 50 years or older with early breast cancer: SITAM-01
    Belfiglio, Maurizio
    Valentini, Miriam
    Pellegrini, Fabio
    De Berardis, Giorgia
    Franciosi, Monica
    Rossi, Maria C. E.
    Sacco, Michele
    Nicolucci, Antonio
    ANNALS OF ONCOLOGY, 2005, 16 : 7 - 7
12345